← Evidence map

ArticleAnnals of translational medicine2021

SIX1/EYA1 are novel liver damage biomarkers in chronic hepatitis B and other liver diseases.

Baoyan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34277792